Featured Articles in the Current Issue
Selective laser trabeculoplasty and some MIGS could reduce the need for incisional surgery.
Optimize outcomes by refining trabeculectomy technique.
New medications and formulations are changing glaucoma treatment.
Better understanding is key to targeted glaucoma treatment.
Thinking outside the eye.
Part 1 of a 4-part physician roundtable on developing advances.
Part 2 of a 4-part physician roundtable on developing advances.
Part 3 of a 4-part physician roundtable on developing advances.
Part 4 of a 4-part physician roundtable on developing advances.
Departments and Columns
Glaucoma News Briefs
- FDA Will Review Sustained-Release Bimatoprost Implant
- Ocular Therapeutix 90-Day Insert Barely Misses Endpoint
- Hydrus Registry Results Presented
- iStent Effective at 3 Years in “Real-World” Study
- Aerpio Studying AKB-9778 for Glaucoma
- Zeiss Enters MIGS Space With Acquisition
- Regenerating Retinal Ganglion Cells
- iSTAR MIGS Procedure Effective at 18 Months
- Microstent Trimmers Launched to Trim Stent Protrusions
- Nicox Glaucoma Medication Begins Phase 2 Trial
- Program Offers Easy Access to Xelpros
- Medical Marijuana Sellers Still Recommend It for Glaucoma
- Catalyst for a Cure Begins New Research Phase
- Glaukos Licenses Novel Drug-Delivery Platform
- PolyActiva Studies Sustained-Release Glaucoma Implant
- Tears Could Provide Clues to Glaucoma Diagnosis
- Glaukos Achieves Strong Sales Growth